Extended Mesenteric Excision for Crohn's Disease
Trial Summary
What is the purpose of this trial?
The study is looking at the role of the mesentery in disease recurrence for ileocolic Crohn's disease. It is a prospective study that has been designed to perform extended mesenteric excision on patients undergoing their first ileocolic resection for Crohn's disease. Endoscopic recurrence will be monitored with the hypothesis that patients receiving extended mesenteric ileocolic resection will have reduced endoscopic recurrence at 6 months after resection.
Research Team
Eligibility Criteria
This trial is for adults over 18 with Crohn's Disease affecting the distal ileum/ileocolic region, who haven't had previous ileocolic resections. It includes all forms of Crohn's presentations like stricturing and fistulizing. Those with prior surgeries in the area or disease in other sites, as well as those with intraabdominal sepsis, cannot participate.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Extended Mesenteric Resection (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montreal General Hospital
Lead Sponsor
Jewish General Hospital
Collaborator
Dr. Justin Cross
Jewish General Hospital
Chief Medical Officer since 2023
MD
Dr. Lawrence Rosenberg
Jewish General Hospital
Chief Executive Officer since 2015
MSc and PhD in Experimental Surgery from McGill University, Master of Engineering from the University of Waterloo